Sarepta Therapeutics, Inc. (SRPT) Financials

SRPT Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 3.2 billion 2.3 billion
2023-12-31 3.3 billion 2.4 billion
2023-09-30 3.1 billion 2.3 billion
2023-06-30 3.1 billion 2.4 billion

SRPT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -274.5 million 40.7 million
2023-12-31 -73.7 million 45.8 million
2023-09-30 -155.6 million 48.1 million
2023-06-30 -140.1 million 47.4 million

SRPT Net Income

No data available :(

SRPT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 1.4 billion - 140.1 million
2023-12-31 1.7 billion - 158.8 million
2023-09-30 1.7 billion - 134.8 million
2023-06-30 1.9 billion - 129.2 million

SRPT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 99.1 million
2023-12-31 105.6 million
2023-09-30 88.9 million
2023-06-30 88.7 million

SRPT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 32.4 million 194.4 million 127.0 million -
2023-12-31 19.0 million 195.5 million 350.2 million 218.5 million
2023-09-30 40.9 million 194.3 million 120.9 million -
2023-06-30 17.9 million 241.9 million 118.6 million -

SRPT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 413.5 million 50.6 million
2023-12-31 396.8 million 44.2 million
2023-09-30 331.8 million 37.0 million
2023-06-30 261.2 million 34.1 million

SRPT

Price: $135.43

52 week price:
55.25
159.89

Payout Ratio Range:
-68.29%
-6.34%

Earnings Per Share: -5.80 USD

P/E Ratio: -15.83

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 366531

Ebitda: -43.3 million

Market Capitalization: 12.6 billion

Links: